Cannabis Science Urges Shareholders to Vote for Cannabis Legalization and Regulation, Nationwide
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is urging shareholders to take part in this year's election by performing the most basic of civic duties: voting.
Shareholders have a unique opportunity to directly help Cannabis Science scale up its operations and reach more customers by helping pass pro-cannabis legislation. With nine states voting on cannabis-related legislation, the potential to greatly expand the company's total attainable market is greater than ever before.
From a medical standpoint, 60% of Americans support marijuana use as per polls by Gallup. This has climbed from 12% in 1969. As more states have legalized medical marijuana and the impact of positive treatment results reached more people, public sentiment has greatly improved, and is anticipated to continue following this trend. Additionally, political figureheads such as Nancy Pelosi are voicing their support for Proposition 64, which is a sign that higher ups are starting to see their constituents' progressing opinions on marijuana.
In California, Proposition 64 has seen tremendous support in pre-election polling, but in order for these positive results to come to fruition, it is crucial all supporters cast their vote.
"Our great nation was founded on the principles of giving the people what they want. Right now, that seems to be legalizing cannabis. Make your voice heard and vote on November 8th," said Director, President, CEO & Co-Founder, Raymond C. Dabney. "Our company is ready to start our post-election plan, and we are ready to hit the ground running with our e-commerce website launch and new products."
The company will be launching its new products through multiple new dispensary partners in the State of California as well as through its own e-commerce website that will be launched soon. The new website will allow medical patients to acquire their medications through doctor forms, but it will also allow those who are legally allowed to consume marijuana recreationally the ability to make online purchases.
To ensure you are registered to vote, check your voter registration status quickly and conveniently on the web at https://www.vote.org/am-i-registered-to-vote/
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward- looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.